156 related articles for article (PubMed ID: 30058349)
1. Copeptin levels and invasive hemodynamics in patients with advanced heart failure.
Balling L; Goetze JP; Jung MH; Rossing K; Boesgaard S; Gustafsson F
Biomark Med; 2018 Aug; 12(8):861-870. PubMed ID: 30058349
[TBL] [Abstract][Full Text] [Related]
2. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
[TBL] [Abstract][Full Text] [Related]
3. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
[TBL] [Abstract][Full Text] [Related]
4. Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.
Zabarovskaja S; Hage C; Gabrielsen A; Mellbin L; Lund LH
Heart Lung Circ; 2017 Feb; 26(2):143-149. PubMed ID: 27523461
[TBL] [Abstract][Full Text] [Related]
5. An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.
Blanchard A; Steichen O; De Mota N; Curis E; Gauci C; Frank M; Wuerzner G; Kamenicky P; Passeron A; Azizi M; Llorens-Cortes C
J Clin Endocrinol Metab; 2013 May; 98(5):2084-9. PubMed ID: 23515451
[TBL] [Abstract][Full Text] [Related]
6. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
7. Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction.
Pozsonyi Z; Förhécz Z; Gombos T; Karádi I; Jánoskuti L; Prohászka Z
Heart Lung Circ; 2015 Apr; 24(4):359-67. PubMed ID: 25618448
[TBL] [Abstract][Full Text] [Related]
8. Differential Regulation of Plasma Copeptin Levels in Patients with Heart Failure: A Single-Center Prospective Study.
Iwashita N; Nara N; Sato R; Nakatogawa T; Kobayashi S; Zama S; Mita M; Hishinuma S; Shoji M
Tohoku J Exp Med; 2016 Jul; 239(3):213-21. PubMed ID: 27396431
[TBL] [Abstract][Full Text] [Related]
9. Utility of copeptin for predicting long-term clinical outcomes in patients with heart failure.
Yoshikawa Y; Shiomi H; Kuwahara K; Sowa N; Yaku H; Yamashita Y; Tazaki J; Imai M; Kato T; Saito N; Shizuta S; Ono K; Kimura T
J Cardiol; 2019 May; 73(5):379-385. PubMed ID: 30591319
[TBL] [Abstract][Full Text] [Related]
10. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.
Miller WL; Grill DE; Struck J; Jaffe AS
Am J Cardiol; 2013 Mar; 111(6):880-5. PubMed ID: 23276468
[TBL] [Abstract][Full Text] [Related]
11. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
[TBL] [Abstract][Full Text] [Related]
12. The clinical application value of the plasma copeptin level in the assessment of heart failure with reduced left ventricular ejection fraction: A cross-sectional study.
Xu L; Liu X; Wu S; Gai L
Medicine (Baltimore); 2018 Sep; 97(39):e12610. PubMed ID: 30278578
[TBL] [Abstract][Full Text] [Related]
13. Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.
Miller WL; Hartman KA; Grill DE; Struck J; Bergmann A; Jaffe AS
Heart; 2012 Mar; 98(5):389-94. PubMed ID: 22194151
[TBL] [Abstract][Full Text] [Related]
14. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
15. Copeptin as a biomarker in heart failure.
Balling L; Gustafsson F
Biomark Med; 2014; 8(6):841-54. PubMed ID: 25224940
[TBL] [Abstract][Full Text] [Related]
16. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
[TBL] [Abstract][Full Text] [Related]
17. Association of Copeptin, a Surrogate Marker of Arginine Vasopressin, with Decreased Kidney Function in Sugarcane Workers in Guatemala.
Butler-Dawson J; Dally M; Johnson RJ; Johnson EC; Krisher L; Sánchez-Lozada LG; Griffin BR; Brindley S; Newman LS
Ann Nutr Metab; 2020; 76(1):30-36. PubMed ID: 32172243
[TBL] [Abstract][Full Text] [Related]
18. Severe mitral regurgitation is associated with increased copeptin levels in heart failure with reduced ejection fraction.
Kılıcgedık A; Eroglu E; Kahvecı G; Isgandarov K; Acar E; Ozturk S; Zehir R; Kulahcıoglu S; Toprak C; Yaman A; Izgı IA; Kirma C
Kardiol Pol; 2017; 75(12):1307-1314. PubMed ID: 28715068
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
20. Sexual disparity of copeptin in healthy newborn infants.
Burckhardt MA; Wellmann M; Fouzas S; Lapaire O; Burkhardt T; Benzing J; Bührer C; Szinnai G; Wellmann S
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1750-3. PubMed ID: 25004250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
